Skip to content
healthcare.dev

TEMODAR

NDC 0085-1381, Temozolomide, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.

Product NDC
0085-1381
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022277
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0085-1381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE2.5 mg/mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
0085-1381-01000851381011 VIAL, SINGLE-USE in 1 CARTON (0085-1381-01) / 40 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/046a9011-3911-4d3f-a15f-fbb56d5aad56
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0085-1381

Use it

Look up 0085-1381 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0085-1381 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0085-1381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.